169 related articles for article (PubMed ID: 10430025)
1. Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes?
Nutt SL; Busslinger M
Biol Chem; 1999 Jun; 380(6):601-11. PubMed ID: 10430025
[TBL] [Abstract][Full Text] [Related]
2. Independent regulation of the two Pax5 alleles during B-cell development.
Nutt SL; Vambrie S; Steinlein P; Kozmik Z; Rolink A; Weith A; Busslinger M
Nat Genet; 1999 Apr; 21(4):390-5. PubMed ID: 10192389
[TBL] [Abstract][Full Text] [Related]
3. Allele-specific expression patterns of interleukin-2 and Pax-5 revealed by a sensitive single-cell RT-PCR analysis.
Rhoades KL; Singh N; Simon I; Glidden B; Cedar H; Chess A
Curr Biol; 2000 Jun; 10(13):789-92. PubMed ID: 10898982
[TBL] [Abstract][Full Text] [Related]
4. Essential functions of Pax-5 (BSAP) in pro-B cell development.
Nutt SL; Thévenin C; Busslinger M
Immunobiology; 1997 Dec; 198(1-3):227-35. PubMed ID: 9442394
[TBL] [Abstract][Full Text] [Related]
5. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments.
Nutt SL; Morrison AM; Dörfler P; Rolink A; Busslinger M
EMBO J; 1998 Apr; 17(8):2319-33. PubMed ID: 9545244
[TBL] [Abstract][Full Text] [Related]
6. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
Heavey B; Charalambous C; Cobaleda C; Busslinger M
EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
[TBL] [Abstract][Full Text] [Related]
7. Reversion of B cell commitment upon loss of Pax5 expression.
Mikkola I; Heavey B; Horcher M; Busslinger M
Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
[TBL] [Abstract][Full Text] [Related]
8. C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8.
Dörfler P; Busslinger M
EMBO J; 1996 Apr; 15(8):1971-82. PubMed ID: 8617244
[TBL] [Abstract][Full Text] [Related]
9. Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation.
Morrison AM; Nutt SL; Thévenin C; Rolink A; Busslinger M
Semin Immunol; 1998 Apr; 10(2):133-42. PubMed ID: 9618759
[TBL] [Abstract][Full Text] [Related]
10. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
Nutt SL; Heavey B; Rolink AG; Busslinger M
Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
[TBL] [Abstract][Full Text] [Related]
11. Reduction in DNA binding activity of the transcription factor Pax-5a in B lymphocytes of aged mice.
Anspach J; Poulsen G; Kaattari I; Pollock R; Zwollo P
J Immunol; 2001 Feb; 166(4):2617-26. PubMed ID: 11160324
[TBL] [Abstract][Full Text] [Related]
12. The Pax-5 gene is alternatively spliced during B-cell development.
Zwollo P; Arrieta H; Ede K; Molinder K; Desiderio S; Pollock R
J Biol Chem; 1997 Apr; 272(15):10160-8. PubMed ID: 9092562
[TBL] [Abstract][Full Text] [Related]
13. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
Fuxa M; Busslinger M
J Immunol; 2007 Jun; 178(12):8222-8. PubMed ID: 17600970
[TBL] [Abstract][Full Text] [Related]
14. B-cell commitment: Pax5 is the deciding factor.
Enver T
Curr Biol; 1999 Dec 16-30; 9(24):R933-5. PubMed ID: 10607584
[TBL] [Abstract][Full Text] [Related]
15. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
Souabni A; Cobaleda C; Schebesta M; Busslinger M
Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
[TBL] [Abstract][Full Text] [Related]
16. Plasticity of Pax-5(-/-) pre-B I cells.
Bruno L; Schaniel C; Rolink A
Cells Tissues Organs; 2002; 171(1):38-43. PubMed ID: 12021490
[TBL] [Abstract][Full Text] [Related]
17. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis.
Horcher M; Souabni A; Busslinger M
Immunity; 2001 Jun; 14(6):779-90. PubMed ID: 11420047
[TBL] [Abstract][Full Text] [Related]
18. [Pax-5 genes and CD19 molecules in human myeloma].
Ishikawa H; Kawano M
Rinsho Ketsueki; 2000 May; 41(5):404-7. PubMed ID: 10879100
[No Abstract] [Full Text] [Related]
19. Loss of Pax5 promotes plasma cell differentiation.
Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
[TBL] [Abstract][Full Text] [Related]
20. Activating PAX gene family paralogs to complement PAX5 leukemia driver mutations.
Hart MR; Anderson DJ; Porter CC; Neff T; Levin M; Horwitz MS
PLoS Genet; 2018 Sep; 14(9):e1007642. PubMed ID: 30216339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]